
### [MONDO:0002656](http://purl.obolibrary.org/obo/MONDO_0002656)
**Label:** skin carcinoma

**Subclasses:** [MONDO:0013133](http://purl.obolibrary.org/obo/MONDO_0013133) (melanoma, cutaneous malignant, susceptibility to, 5), [MONDO:0013101](http://purl.obolibrary.org/obo/MONDO_0013101) (BCC2), [MONDO:0013102](http://purl.obolibrary.org/obo/MONDO_0013102) (BCC3), [MONDO:0013510](http://purl.obolibrary.org/obo/MONDO_0013510) (melanoma, cutaneous malignant, susceptibility to, 6), [MONDO:0012183](http://purl.obolibrary.org/obo/MONDO_0012183) (melanoma, cutaneous malignant, susceptibility to, 3), [MONDO:0014368](http://purl.obolibrary.org/obo/MONDO_0014368) (melanoma, cutaneous malignant, susceptibility to, 10), [MONDO:0018961](http://purl.obolibrary.org/obo/MONDO_0018961) (familial melanoma), [MONDO:0014056](http://purl.obolibrary.org/obo/MONDO_0014056) (melanoma, cutaneous malignant, susceptibility to, 9), [MONDO:0007965](http://purl.obolibrary.org/obo/MONDO_0007965) (melanoma, malignant familial intraocular), [MONDO:0007964](http://purl.obolibrary.org/obo/MONDO_0007964) (dysplastic nevus syndrome), [MONDO:0007963](http://purl.obolibrary.org/obo/MONDO_0007963) (CMM1), [MONDO:0011556](http://purl.obolibrary.org/obo/MONDO_0011556) (BCC1), [MONDO:0012842](http://purl.obolibrary.org/obo/MONDO_0012842) (CMM7), [MONDO:0013759](http://purl.obolibrary.org/obo/MONDO_0013759) (MITF-related melanoma and renal cell carcinoma predisposition syndrome), [MONDO:0011465](http://purl.obolibrary.org/obo/MONDO_0011465) (infundibulocystic basal cell carcinoma), [MONDO:0013104](http://purl.obolibrary.org/obo/MONDO_0013104) (BCC4), [MONDO:0013105](http://purl.obolibrary.org/obo/MONDO_0013105) (BCC5), [MONDO:0011954](http://purl.obolibrary.org/obo/MONDO_0011954) (CMM4), [MONDO:0013876](http://purl.obolibrary.org/obo/MONDO_0013876) (basal cell carcinoma, susceptibility to, 7), [MONDO:0013106](http://purl.obolibrary.org/obo/MONDO_0013106) (BCC6), 

**Corr. equiv. classes:** [Orphanet:293822](http://www.orpha.net/ORDO/Orphanet_293822), [OMIM:613061](http://purl.obolibrary.org/obo/OMIM_613061), [OMIM:155601](http://purl.obolibrary.org/obo/OMIM_155601), [OMIM:613063](http://purl.obolibrary.org/obo/OMIM_613063), [OMIM:155700](http://purl.obolibrary.org/obo/OMIM_155700), [OMIM:613062](http://purl.obolibrary.org/obo/OMIM_613062), [OMIM:155600](http://purl.obolibrary.org/obo/OMIM_155600), [OMIM:614740](http://purl.obolibrary.org/obo/OMIM_614740), [OMIM:612263](http://purl.obolibrary.org/obo/OMIM_612263), [OMIM:613099](http://purl.obolibrary.org/obo/OMIM_613099), [OMIM:613058](http://purl.obolibrary.org/obo/OMIM_613058), [OMIM:615134](http://purl.obolibrary.org/obo/OMIM_615134), [Orphanet:618](http://www.orpha.net/ORDO/Orphanet_618), [OMIM:613972](http://purl.obolibrary.org/obo/OMIM_613972), [OMIM:613059](http://purl.obolibrary.org/obo/OMIM_613059), [OMIM:614456](http://purl.obolibrary.org/obo/OMIM_614456), [OMIM:615848](http://purl.obolibrary.org/obo/OMIM_615848), [OMIM:605462](http://purl.obolibrary.org/obo/OMIM_605462), [OMIM:608035](http://purl.obolibrary.org/obo/OMIM_608035), [OMIM:604451](http://purl.obolibrary.org/obo/OMIM_604451), [OMIM:609048](http://purl.obolibrary.org/obo/OMIM_609048), 

**Class expressions from DL-Learner:**

- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 21.19%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000021](http://purl.obolibrary.org/obo/HP_0000021) (Megacystis))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000019](http://purl.obolibrary.org/obo/HP_0000019) (Urinary hesitancy))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 21.15%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 21.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000018](http://purl.obolibrary.org/obo/HP_0000018) (null))) 21.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000017](http://purl.obolibrary.org/obo/HP_0000017) (Nocturia))) 21.14%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 21.14%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.93%
- Thing 20.48%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 20.48%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 18.02%


